journal
MENU ▼
Read by QxMD icon Read
search

Clinical Advances in Hematology & Oncology: H&O

journal
https://www.readbyqxmd.com/read/30256778/distinguishing-autoimmune-myelofibrosis-from-primary-myelofibrosis
#1
REVIEW
Bridget Marcellino, Siraj M El Jamal, John O Mascarenhas
Bone marrow fibrosis (BMF) is a histologic finding in a wide range of diseases, including malignancies, endocrine disorders, autoimmune diseases, and infections. Autoimmune myelofibrosis (AIMF) is an uncommon etiology of BMF; it can be secondary to a defined autoimmune disease, or it can be primary in the absence of a clinically diagnosed autoimmune disease but the presence of serologic evidence of autoantibodies. Distinguishing between primary myelofibrosis (PMF) and non-neoplastic AIMF is of the utmost importance because the prognosis and therapeutic options are different...
September 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30256777/changing-local-therapy-in-breast-cancer-who-needs-what-and-when
#2
REVIEW
Batul H Al-Zubeidy, Hannah Weiss, Seema A Khan
The local therapy of breast cancer continues to evolve toward less surgery. Breast conservation is firmly in place, with recent trends toward decreased rates of re-excision. Axillary dissection is becoming a rare operation and is being replaced by sentinel node biopsy. The switch to sentinel node biopsy occurred first in patients with pathologically tumor-free nodes, and later in patients with limited nodal disease. Sentinel node biopsy is now also widely used in patients with pathologically positive nodes who receive neoadjuvant chemotherapy...
September 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30256776/dosing-drugs-in-elderly-patients-with-cancer
#3
Arti Hurria
No abstract text is available yet for this article.
September 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30256775/diagnosis-and-management-of-dysfibrinogenemia
#4
Susan E Shapiro
No abstract text is available yet for this article.
September 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30256774/update-on-managing-brain-metastases-in-breast-cancer
#5
Nancy U Lin
No abstract text is available yet for this article.
September 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30256773/refining-the-management-of-polycythemia-vera
#6
Ruben A Mesa
No abstract text is available yet for this article.
September 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30300340/highlights-in-chronic-lymphocytic-leukemia-from-the-23rd-congress-of-the-european-hematology-association
#7
(no author information available yet)
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30300339/clinical-implications-of-the-2018-iwcll-guidelines-update
#8
Susan M O'Brien
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30300338/advances-in-aggressive-lymphoma-from-the-2018-american-society-of-clinical-oncology-annual-meeting-commentary
#9
Frederick L Locke, Michael D Jain
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30300337/advances-in-aggressive-lymphoma-from-the-2018-american-society-of-clinical-oncology-annual-meeting
#10
(no author information available yet)
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30300336/highlights-in-lymphoma-from-the-2018-american-society-of-clinical-oncology-annual-meeting-commentary
#11
Robert W Chen
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30300335/highlights-in-lymphoma-from-the-2018-american-society-of-clinical-oncology-annual-meeting
#12
(no author information available yet)
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30148829/the-evolving-role-of-transplantation-in-multiple-myeloma-the-need-for-a-heterogeneous-approach-to-a-heterogeneous-disease
#13
REVIEW
Sara Gandolfi, Carolyn Vekstein, Jacob P Laubach, Alexandra O'Brien, Kelly Masone, Nikhil C Munshi, Kenneth C Anderson, Paul G Richardson
Autologous stem cell transplant (ASCT) is an established frontline standard of care for the younger, fitter patients with newly diagnosed multiple myeloma (NDMM) who are eligible for the procedure, and has contributed to improved overall survival. In the current era of novel therapies, the treatment landscape and prognosis have changed. The outstanding efficacy seen with regimens based on novel agents has led to a questioning of the frontline treatment paradigm with respect to ASCT. A key current question is whether to use transplant early or to collect stem cells early but save ASCT for salvage therapy...
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30148828/adjuvant-treatment-in-renal-cell-carcinoma
#14
REVIEW
Nazli Dizman, Jacob J Adashek, JoAnn Hsu, Paulo G Bergerot, Cristiane D Bergerot, Sumanta K Pal
In parallel with advances in the treatment of metastatic renal cell carcinoma (RCC), multiple adjuvant treatments have been tested for RCC. Adjuvant approaches now extend beyond conventional immunotherapies, such as interferon alfa and interleukins, to targeted therapies and immune checkpoint inhibitors. Most treatment approaches before the targeted treatment era did not improve patient outcomes, or study results were mixed. For example, a recent study found that disease-free survival was longer with sunitinib than with placebo in high-risk clear cell RCC, which led to the regulatory approval of sunitinib...
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30148827/chemoprevention-of-colorectal-cancer-aspirin-and-beyond
#15
Paul J Limburg
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30148826/weight-based-dosing-vs-fixed-dosing-of-pembrolizumab-an-economic-analysis
#16
Daniel Goldstein
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30148825/immunotherapy-in-the-adjuvant-setting-for-high-risk-melanoma
#17
Jeffrey S Weber
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30148824/highlights-in-breast-cancer-from-the-2018-american-society-of-clinical-oncology-annual-meeting
#18
Hope S Rugo
No abstract text is available yet for this article.
August 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30235180/highlights-in-chronic-lymphocytic-leukemia-from-the-2018-american-society-of-clinical-oncology-annual-meeting-commentary
#19
Susan M O'Brien
No abstract text is available yet for this article.
July 2018: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/30235179/highlights-in-chronic-lymphocytic-leukemia-from-the-2018-american-society-of-clinical-oncology-annual-meeting
#20
(no author information available yet)
No abstract text is available yet for this article.
July 2018: Clinical Advances in Hematology & Oncology: H&O
journal
journal
40386
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"